SEC 13F Intelligence

Athanor Capital, LP / IMMU

Athanor Capital, LP’s Immunomedics Inc Position

Does Athanor Capital, LP own Immunomedics Inc (IMMU)? Not currently — the last reported position was 207.0K shares worth $18M in Q3 2020; the fund’s latest 13F (Q1 2023) no longer reports it.

Position Value
$18M
Q3 2020
Shares
207.0K
% of Portfolio
+0.67%
Quarters Held
2
position exited

Position History IMMU

Reported value by quarter
Q2 ’20: $750,000Q2 ’20Q3 ’20: $18MQ3 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2020207.0K$18M+0.67%
Q2 202021.2K$750,000+0.04%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Athanor Capital, LP’s full portfolio or all institutional holders of IMMU.